Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03847337 · ClinicalTrials.gov registry record · NA

Can Novel Telemedicine Tools Reduce Disparities Related to Early Identification of Autism

A NA study of Autism Spectrum Disorder and Developmental Delay, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
144
Enrollment target
1
Study location

NCT03847337 is a NA study of Autism Spectrum Disorder and Developmental Delay that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 144 participants, roughly in line with the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03847337, a NA study of Autism Spectrum Disorder and Developmental Delay, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
144 participants
Enrollment target
1
Study location

Study Summary

In this study, the investigators are trying to find new ways to screen for autism spectrum disorder (ASD) in young children. The investigators want to see if people like pediatricians can screen children for ASD while a psychologist watches on a monitor. The investigators are testing two screening tools. The investigators want to see if they are good at identifying children with ASD and children without ASD. The investigators hope this research will make it easier for families to get answers when there are concerns for ASD.

Interventions

  • OTHER Telehealth-Screening Tool for Autism in Toddlers (STAT)
  • OTHER Telehealth-Autism Spectrum Disorder-Pediatrics (ASD-PEDS)

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2019-03-04
Est. Completion 2021-09-30
Phase NA

What the Registry Record Tells You About NCT03847337

The ClinicalTrials.gov registry entry for NCT03847337 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Telehealth-Screening Tool for Autism in Toddlers (STAT) is the first listed.

NCT03847337 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT03847337 about?

NCT03847337 is a clinical study titled "Can Novel Telemedicine Tools Reduce Disparities Related to Early Identification of Autism". In this study, the investigators are trying to find new ways to screen for autism spectrum disorder (ASD) in young children. The investigators want to see if people like pediatricians can screen children for ASD while a psychologist watches on a monitor. The investigators are testing two screening t...

What is the current status of trial NCT03847337?

This trial is currently completed. It is a NA study. The enrollment target is 144 participants. The study started on 2019-03-04. Estimated completion is 2021-09-30.

What conditions does trial NCT03847337 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Developmental Delay.

What interventions are being tested in trial NCT03847337?

The interventions under investigation include: Telehealth-Screening Tool for Autism in Toddlers (STAT) (OTHER), Telehealth-Autism Spectrum Disorder-Pediatrics (ASD-PEDS) (OTHER).

Who is sponsoring clinical trial NCT03847337?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03847337 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.